In September 1995, the FDA at first accepted testosterone transdermal patches (Androderm); numerous transdermal forms and types at the moment are out there including implants, gels, and topical remedies. A testosterone buccal process, Striant, was FDA authorised in July 2003; the technique is a mucoadhesive product that adheres towards the buccal m